Jacobson & Schmitt Advisors LLC raised its holdings in Danaher Co. (NYSE:DHR) by 2.0% in the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 61,004 shares of the conglomerate’s stock after purchasing an additional 1,214 shares during the period. Danaher accounts for about 5.1% of Jacobson & Schmitt Advisors LLC’s holdings, making the stock its 4th biggest position. Jacobson & Schmitt Advisors LLC’s holdings in Danaher were worth $8,719,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also bought and sold shares of DHR. MBM Wealth Consultants LLC grew its stake in Danaher by 2.0% in the 2nd quarter. MBM Wealth Consultants LLC now owns 3,701 shares of the conglomerate’s stock worth $529,000 after buying an additional 74 shares in the last quarter. Mechanics Bank Trust Department grew its stake in Danaher by 1.7% in the 2nd quarter. Mechanics Bank Trust Department now owns 4,384 shares of the conglomerate’s stock worth $627,000 after buying an additional 75 shares in the last quarter. Adirondack Trust Co. lifted its holdings in shares of Danaher by 3.1% in the 1st quarter. Adirondack Trust Co. now owns 2,635 shares of the conglomerate’s stock worth $349,000 after acquiring an additional 78 shares during the last quarter. HL Financial Services LLC lifted its holdings in shares of Danaher by 0.4% in the 1st quarter. HL Financial Services LLC now owns 19,148 shares of the conglomerate’s stock worth $2,528,000 after acquiring an additional 79 shares during the last quarter. Finally, Cornerstone Advisors Inc. lifted its holdings in shares of Danaher by 2.9% in the 1st quarter. Cornerstone Advisors Inc. now owns 2,783 shares of the conglomerate’s stock worth $367,000 after acquiring an additional 79 shares during the last quarter. Hedge funds and other institutional investors own 79.49% of the company’s stock.

NYSE:DHR traded up $0.10 during midday trading on Wednesday, reaching $140.17. 49,266 shares of the stock traded hands, compared to its average volume of 2,103,424. The company has a fifty day moving average of $141.20 and a 200 day moving average of $131.85. Danaher Co. has a 12 month low of $94.59 and a 12 month high of $145.50. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.91 and a current ratio of 2.32. The stock has a market capitalization of $100.68 billion, a P/E ratio of 31.01, a PEG ratio of 2.53 and a beta of 0.94.

Danaher (NYSE:DHR) last posted its quarterly earnings results on Thursday, July 18th. The conglomerate reported $1.19 EPS for the quarter, beating the Zacks’ consensus estimate of $1.15 by $0.04. Danaher had a net margin of 12.22% and a return on equity of 11.53%. The company had revenue of $5.16 billion during the quarter, compared to analyst estimates of $5.09 billion. During the same period in the prior year, the business posted $1.15 EPS. The firm’s revenue was up 3.5% compared to the same quarter last year. On average, analysts predict that Danaher Co. will post 4.79 EPS for the current fiscal year.

In related news, SVP William King sold 12,950 shares of the company’s stock in a transaction on Wednesday, May 29th. The shares were sold at an average price of $129.92, for a total transaction of $1,682,464.00. Following the completion of the sale, the senior vice president now directly owns 29,070 shares in the company, valued at approximately $3,776,774.40. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, insider Brian W. Ellis sold 1,010 shares of the company’s stock in a transaction on Friday, July 26th. The shares were sold at an average price of $144.04, for a total transaction of $145,480.40. Following the sale, the insider now owns 20,889 shares of the company’s stock, valued at $3,008,851.56. The disclosure for this sale can be found here. Insiders have sold a total of 354,316 shares of company stock valued at $48,598,531 over the last quarter. 11.40% of the stock is currently owned by company insiders.

A number of brokerages have recently weighed in on DHR. Argus boosted their price objective on shares of Danaher to $165.00 and gave the stock a “buy” rating in a report on Tuesday, July 23rd. Royal Bank of Canada set a $134.00 price objective on shares of Danaher and gave the stock a “hold” rating in a report on Friday, July 19th. Piper Jaffray Companies boosted their price objective on shares of Danaher from $148.00 to $153.00 and gave the stock a “neutral” rating in a report on Thursday, July 18th. Robert W. Baird boosted their price objective on shares of Danaher from $131.00 to $148.00 and gave the stock an “outperform” rating in a report on Friday, July 19th. Finally, Wolfe Research began coverage on shares of Danaher in a report on Thursday, May 30th. They issued an “outperform” rating for the company. Three investment analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the company. The stock presently has a consensus rating of “Buy” and a consensus target price of $143.54.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company's Life Sciences segment provides mass spectrometers; cellular analysis, lab automation, and centrifugation instruments; microscopes; and genomics consumables.

See Also: Technical Analysis of Stocks and What It Means

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.